Nevertheless, other studies have indicated that mutations in RAD51C [22] and RAD51D [17, 23, 24] contribute to the risk of both breast and ovarian cancer, and that RAD50 is an intermediate-risk breast cancer susceptibility gene [25]. The gene discussed is RAD51D; the disease is breast carcinoma.